ANN ARBOR, Mich., April 12, 2010 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced the appointments of Daniel R. Salomon, M.D., Karen K. Hirschi, Ph.D., Marc Penn, M.D., Ph.D., FACC, and Mahendra Rao, M.D., Ph.D., to its newly formed scientific advisory board (SAB). These distinguished scientists and clinicians will provide guidance to Aastrom in their respective areas of expertise in stem cell biology and cardiovascular disease.
